Skip to content

Unlocking the Potential of the Proteome

Accelerating drug discovery through expert scientific knowledge and cutting-edge proteomics technology.

OUR MISSION

Gene2Lead offers AI-integrated technology service platforms that explore biomolecules and generate novel therapeutics with applications to a range of diseases and organisms.

Learn More

G2L Validate

Identify novel binding sites and therapeutic targets in the dark proteome

Spot out false positives in chemoproteomics data

Explore polypharmacological effect of drugs

Prioritize chemoproteomics data using omics inference and ligandability assessment platforms

G2L Discover

Examine protein targets for cryptic covalent/non-covalent hotspots

Examine variants of a target for covalent hotspots

Perform “virtual” chemoproteomics on therapeutic target proteins

Interested in learning more about our services?

Click Here

Who We Are

We are a scientific consulting team that provides expert services and solutions to academic and industrial drug discovery programs in Canada and across the world. We receive client projects at the level of a target gene of interest or proteomics data and work it through custom semi-automated project pipeline that involves state-of-the-art technologies and AI-powered computational platforms to facilitate discovery of new lead compounds against their disease linked target.

Have any Questions?

Contact us by filling out this form